Different antihyperglycaemic drug effects on glycaemic variability in Type 2 diabetic patients

Different antihyperglycaemic drug effects on glycaemic variability in Type 2 diabetic patients

Optimizing treatments for type 2 diabetes mellitus (T2DM) remains an urgent issue. In addition to T2DM treatment strategies, such as glycaemic goals (glucose and glycated haemoglobin ? HbА1c) among different patient populations, the influence of glycaemic variability (GV) on the prognosis of patient...

Full description

Saved in:

Bibliographic Details
Main Authors:	Alina Babenko, Elena Ivanovna Krasilnikova, Nikolay Pavlovich Likhonosov, Anna Pavlovna Likhonosova, Elena Nikolaevna Grineva
Format:	Article
Language:	English
Published:	Endocrinology Research Centre 2014-12-01
Series:	Сахарный диабет
Subjects:	continuous glucose monitoring glycaemic variability incretins glp-1 analogues/mimetics dpp-4 inhibitors
Online Access:	https://www.dia-endojournals.ru/jour/article/view/6406
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Are GLP-1 Analogues a New Solution for the Treatment of NAFLD?
by: Maria Sudoł, et al.
Published: (2024-12-01)

Glycaemic variability in diabetes: a tool for assessing the quality of glycaemic control and the risk of complications
by: Vadim Valer'evich Klimontov, et al.
Published: (2014-07-01)

Symptomatic Adverse Events and Quality of Life Related to Incretin-Based Medicines for Obesity: A Systematic Review Involving >400,000 Subjects
by: Robert F. Kushner, et al.
Published: (2025-04-01)

Assessment of Correlation Between Glycaemic Variability Indices and Measures of Hypoglycaemia in Patients with Type 2 Diabetes Mellitus
by: Arjun Suresh, et al.
Published: (2024-11-01)

Clinical implementetion of vildagliptin: data from recent studies comparing incretin-based medications
by: Elena Valer'evna Biryukova
Published: (2014-03-01)

Chapter 11: The approach to achieving glycaemic control
by: The Society for Endocrinology Metabolism and Diabetes of South Africa
Published: (2018-06-01)

Orchestrating Metabolic Homeostasis: The Role of Gut Hormones in Next-Generation Therapies for Metabolic Syndrome
by: Tamer A. Addissouky
Published: (2025-05-01)

Bidirectional Interactions Between the Gut Microbiota and Incretin-Based Therapies
by: Vincenzo Trapanese, et al.
Published: (2025-05-01)

New prospects in the treatment of diabetes mellitus
by: Minara Shamkhalovna Shamkhalova, et al.
Published: (2012-12-01)

Modern antihyperglycemic agents prescribed in Russia for type 2 diabetes mellitus
by: Yury Ivanovich Suntsov
Published: (2012-03-01)

Impact of Intensive Insulin Stabilisation Service in Pregnancy with Type 1 Diabetes
by: Stephanie Teasdale, et al.
Published: (2024-12-01)

Role of incretin based therapies in the treatment of diabetic kidney disease
by: Paola Fioretto, et al.
Published: (2018-11-01)

PANCREATIC AND EXTRA-PANCREATIC EFFECTS OF INCRETINS AND PERSPECTIVES FOR STUDYING ENTEROINSULIN HORMONAL SYSTEM DURING GESTATIONAL DISORDER OF CARBOHYDRATE METABOLISM
by: T. V. Saprina, et al.
Published: (2013-06-01)

First GLP-1 analog liraglutide: the result of clinical trails on efficacy
by: Alexander Sergeevich Ametov, et al.
Published: (2011-12-01)

Fasting GLP-1 Levels in Women with PCOS and CAH
by: Robeva R., et al.
Published: (2024-12-01)

Glycaemic control: Do no harm
by: L. Kelly
Published: (2012-02-01)

Specific loss of GIPR signaling in GABAergic neurons enhances GLP-1R agonist-induced body weight loss
by: Jordan Wean, et al.
Published: (2025-05-01)

Efficacy of GLP-1 analog to achieve metabolic control and correction of body weight in patients with type 2 diabetes mellitus
by: T. V. Saprina, et al.
Published: (2011-12-01)

New indications for exenatide therapy of type 2 diabetes mellitus
by: Olga Konstantinovna Vikulova, et al.
Published: (2010-09-01)

CARDIOPRODUCTIVE EFFECTS OF EXXENATE AMID AND VILDAGLIPTIN INCRETIN MIMETICS IN DOXYRUBRICINE CARDIOMYOPATHY MODELING
by: A. P. TARASOVА, et al.
Published: (2017-09-01)

Glucose-dependent insulinotropic polypeptide (GIP)
by: Timo D. Müller, et al.
Published: (2025-05-01)

Association between Physical Activity Energy Expenditure and Continuous Glucose Monitor-Derived Metrics: Data from the ZOE PREDICT 1 Study
by: Harry A. Smith, et al.
Published: (2023-12-01)

Ileal transposition in surgical treatment for type 2 diabetes mellitus
by: Oleg Viktorovich Kornyushin, et al.
Published: (2015-03-01)

Dipeptidyl peptidase-4 inhibitors: their role in the management of type 2 diabetes
by: Gail Mkele
Published: (2013-12-01)

The Application of Incretin-Based Pharmacotherapy in the Contemporary Management of Type 2 Diabetes: A Review of the Literature
by: Jakub Waszczyński, et al.
Published: (2025-01-01)

Impact of Incretin Mimetics on Thyroid Cancer Among Patients with Type 2 Diabetes: A Retrospective Cohort Time-to-Event Analysis
by: Michael W. Strand, et al.
Published: (2025-04-01)

Effect of high intakes of protein-only and carbohydrate-only on plasma metabolites and hormones, in addition to nitrogen excretion
by: Matthieu Clauss, et al.
Published: (2025-08-01)

Editorial: Incretin-based therapies in the treatment of metabolic syndrome: expanding roles beyond weight management
by: Kexin Zhang, et al.
Published: (2025-08-01)

Effect of GIP and GLP-1 infusion on bone resorption in glucose intolerant, pancreatic insufficient cystic fibrosis
by: Wang Shin Lei, et al.
Published: (2025-06-01)

Tirzepatide, a dual GIP/GLP1-receptor co-agonist preserves cardiac function and improves survival in angiotensin II-induced heart failure model in mice: comparison to liraglutide
by: Zsombor I. Hegedűs, et al.
Published: (2025-06-01)

Comparison of glycaemic index of honey and sports energy products
by: Nives Brekalo, et al.
Published: (2024-12-01)

Diurnal Differences in Glycaemic Responses to Meals Containing Different Bread Types among Persons at Risk for Type 2 Diabetes—Preliminary Results from a CarbHealth Sub-Study
by: Alena M. Schadow, et al.
Published: (2024-02-01)

Increase in circulating GLP-1 following low FODMAP diet in irritable bowel syndrome patients
by: Umael Khan, et al.
Published: (2025-08-01)

Vildagliptin and its role in the treatment of diabetes mellitus
by: Yury Shavkatovich Khalimov
Published: (2010-09-01)

Cooking Increased the Postprandial Glycaemic Response but Enhanced the Preload Effect of Air-Dried Jujube
by: Jinjie Wei, et al.
Published: (2025-03-01)

Insulin degludec: a new basal insulin analogue with an ultra-long duration of action. Safety and efficacy in Russian patients with diabetes
by: Marina Vladimirovna Shestakova, et al.
Published: (2015-12-01)

Comparative effectiveness of different exercise modality on glycaemic control and lipid profile for prediabetes: systematic review and network meta-analysis
by: Ruixiang Yan, et al.
Published: (2025-07-01)

The first and only combination of basal and prandial insulin analogs degludec and aspart: the position of Russian endocrinologists
by: M. V. Shestakova, et al.
Published: (2021-07-01)

Coping strategies in Type 1 and Type 2 diabetes patients using insulin: the relationship with emotional well-being and glycaemic control
by: Oleg G. Motovilin, et al.
Published: (2015-12-01)

Perspectives of impaired glucose tolerance management in patients with metabolic syndrome
by: K. P. Ivanov, et al.
Published: (2011-08-01)